qCT

Riverain Technologies' ClearRead Xray is a suite of five FDA-cleared applications designed to enhance the efficiency and accuracy of chest X-ray interpretation across healthcare enterprises without necessitating additional equipment, procedures, or radiation exposure. The platform employs unique suppression technology to provide an unobstructed view of the chest, facilitating the rapid and accurate detection of cardiothoracic diseases. Key features include the production of bone-suppressed images for improved visualization, identification of potential lung cancer nodules, reduction in portable X-ray reading time, automatic comparison of findings with prior exams to highlight changes, and enterprise-wide compatibility across various manufacturers and imaging protocols. Notably, ClearRead Xray Bone Suppress increases the visibility of soft tissue by suppressing bone structures in digital images, aiding radiologists in detecting previously missed nodules.

Hermia is a sophisticated, vendor-neutral molecular imaging suite designed to unify and streamline clinical workflows across nuclear medicine, PET/SPECT/CT/MR reviewing, and advanced imaging analysis while supporting scanners and DICOM data from any manufacturer, enabling facilities to choose hardware freely and consolidate multiple legacy systems into one platform. It offers high-performance multimodality image display and analysis with intuitive, customizable workflows that accelerate reporting, improve data visualization, and reduce manual steps from acquisition through interpretation, facilitating fast and accurate review of PET/CT, SPECT/CT, and PET/MR studies. Hermia’s comprehensive toolset includes optimized SPECT reconstruction for diverse procedures and radio-pharmaceuticals, a broad nuclear medicine processing toolkit for osteology, gastroenterology, nephrology, and endocrinology, and specialized modules for pneumology with lung function and SPECT V/Q quantification.